loadpatents
name:-0.012363910675049
name:-0.011716842651367
name:-0.00039196014404297
Vossen; Marcus Patent Filings

Vossen; Marcus

Patent Applications and Registrations

Patent applications and USPTO patent grants for Vossen; Marcus.The latest application filed is for "multicomponent crystals of dasatinib with menthol or vanillin".

Company Profile
0.13.9
  • Vossen; Marcus - Limburgerhof DE
  • Vossen; Marcus - Kassel DE
  • Vossen; Marcus - Mannheim DE
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Multi-component crystals of vismodegib and selected co-crystal formers or solvents
Grant 10,105,355 - Viertelhaus , et al. October 23, 2
2018-10-23
Multicomponent Crystals Of Dasatinib With Menthol Or Vanillin
App 20180230140 - VIERTELHAUS; Martin ;   et al.
2018-08-16
Solid form of abiraterone acetate
Grant 10,045,998 - Chiodo , et al. August 14, 2
2018-08-14
Salts of dasatinib in amorphous form
Grant 9,884,857 - Hafner , et al. February 6, 2
2018-02-06
Multi-component Crystals Of Vismodegib And Selected Co-crystal Formers Or Solvents
App 20170216266 - VIERTELHAUS; MARTIN ;   et al.
2017-08-03
Multicomponent crystalline system comprising nilotinib and selected co-crystal formers
Grant 9,567,317 - Chiodo , et al. February 14, 2
2017-02-14
Salts of Dasatinib in crystalline form
Grant 9,556,164 - Hafner , et al. January 31, 2
2017-01-31
Solid Form Of Abiraterone Acetate
App 20160303143 - CHIODO; Tiziana ;   et al.
2016-10-20
Salts Of Dasatinib In Crystalline Form
App 20160168143 - HAFNER; Andreas ;   et al.
2016-06-16
Multicomponent crystals comprising dasatinib and selected co-crystal formers
Grant 9,340,536 - Chiodo , et al. May 17, 2
2016-05-17
Multicomponent crystalline system comprising deferasirox and isonicotinamide and a process for the preparation thereof
Grant 9,290,452 - Hafner , et al. March 22, 2
2016-03-22
Multicomponent crystals comprising imatinib mesilate and selected co-crystal formers
Grant 9,221,789 - Chiodo , et al. December 29, 2
2015-12-29
Multicomponent Crystalline System Comprising Nilotinib And Selected Co-crystal Formers
App 20150246901 - Chiodo; Tiziana ;   et al.
2015-09-03
Multicomponent Crystalline System Comprising Deferasirox And Isonicotinamide And A Process For The Preparation Thereof
App 20150175544 - Hafner; Andreas ;   et al.
2015-06-25
Multicomponent Crystals Comprising Dasatinib And Selected Co-crystal Formers
App 20150133463 - Chiodo; Tiziana ;   et al.
2015-05-14
Multicomponent Crystals Comprising Imatinib Mesilate And Selected Co-crystal Formers
App 20150126520 - Chiodo; Tiziana ;   et al.
2015-05-07
Method of producing a cyclohexenone oxime ether lithium salt, products which can be obtained using this method, the use thereof and corresponding plant protection agents
Grant 6,989,453 - Maywald , et al. January 24, 2
2006-01-24
Method for producing a cyclohexenone oxime ether lithium salt, products which can be obtained using this method, the use thereof and corresponding plant protection agents
App 20040014988 - Maywald, Volker ;   et al.
2004-01-22
N-aminopyridone derivatives and their use as herbicides
Grant 6,028,033 - Hill , et al. February 22, 2
2000-02-22
2-Anylocyclohexanediones having improved herbicidal properties
Grant 6,004,903 - von Deyn , et al. December 21, 1
1999-12-21
Herbicidally active phenyldiketone compounds
Grant 5,846,906 - von Deyn , et al. December 8, 1
1998-12-08
Herbicidally active pyrazol-4-ylbenzoyl compounds
Grant 5,846,907 - von Deyn , et al. December 8, 1
1998-12-08

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed